Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Caudate Nucleus (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Caudate Nucleus (drug effects) < Caudate Nucleus (metabolism) < Caudate Nucleus (pathology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000203 (2002) Frédéric Calon [Canada] ; Sam Birdi ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloIncrease of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
000269 (2003) Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim ; Vesna Sossi ; Michael J. Adam ; Thomas J. Ruth ; Donald B. Calne ; A Jon Stoessl ; Chong S. LeeAge and severity of nigrostriatal damage at onset of Parkinson's disease.
000449 (2004) Raúl De La Fuente-Fernández [Canada] ; Vesna Sossi ; Zhigao Huang ; Sarah Furtado ; Jian-Qiang Lu ; Donald B. Calne ; Thomas J. Ruth ; A Jon StoesslLevodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
000707 (2007) Philippe Huot [Canada] ; Martin Lévesque ; André ParentThe fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
000986 (2009) A R Troiano [Canada] ; R. De La Fuente-Fernandez ; V. Sossi ; M. Schulzer ; E. Mak ; T J Ruth ; A J StoesslPET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
000B32 (2009) R. Nandhagopal ; L. Kuramoto ; M. Schulzer ; E. Mak ; J. Cragg ; Chong S. Lee ; J. Mckenzie ; S. Mccormick ; A. Samii ; A. Troiano ; T J Ruth ; V. Sossi ; R. De La Fuente-Fernandez ; Donald B. Calne ; A J StoesslLongitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.
000B70 (1991) H B Niznik [Canada] ; E F Fogel ; F F Fassos ; P. SeemanThe dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus.
000C12 (2010) Bazoumana Ouattara [Canada] ; Fabrizio Gasparini ; Marc Morissette ; Laurent Grégoire ; Pershia Samadi ; Baltazar Gomez-Mancilla ; Thérèse Di PaoloEffect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
000F73 (1990) P. Seeman [Canada] ; H B NiznikDopamine receptors and transporters in Parkinson's disease and schizophrenia.
001C10 (2015) Junchao Tong [Canada] ; Lee-Cyn Ang [Canada] ; Belinda Williams [Canada] ; Yoshiaki Furukawa [Japon] ; Paul Fitzmaurice [Nouvelle-Zélande] ; Mark Guttman [Canada] ; Isabelle Boileau [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada]Low Levels of Astroglial Markers in Parkinson's Disease: Relationship to α-Synuclein Accumulation
001F19 (2016) Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
002341 (1988) S J Kish [Canada] ; K. Shannak ; O. HornykiewiczUneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.
002411 (1995) H. Kuwabara [Canada] ; P. Cumming ; Y. Yasuhara ; G C Léger ; M. Guttman ; M. Diksic ; A C Evans ; A. GjeddeRegional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
002493 (1993) H. Hoshi [Canada] ; H. Kuwabara ; G. Léger ; P. Cumming ; M. Guttman ; A. Gjedde6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.
002606 (1997) H. Shinotoh [Canada] ; B. Thiessen ; B J Snow ; S. Hashimoto ; P. Macleod ; I. Silveira ; G A Rouleau ; M. Schulzer ; D B CalneFluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
002617 (1997) M. Morissette [Canada] ; M. Goulet ; J J Soghomonian ; P J Blanchet ; F. Calon ; P J Bédard ; T. Di PaoloPreproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Caudate Nucleus (metabolism)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Caudate Nucleus (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Caudate Nucleus (metabolism)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022